SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001480
Filing Date
2019-10-01
Accepted
2019-10-01 08:14:12
Documents
14
Period of Report
2019-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530212_8k.htm   iXBRL 8-K 30522
2 EXHIBIT 99.1 tv530212_ex99-1.htm EX-99.1 7525
3 GRAPHIC tv530212_ex99-1img01.jpg GRAPHIC 10598
  Complete submission text file 0001410578-19-001480.txt   227394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adap-20190930.xsd EX-101.SCH 3196
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20190930_lab.xml EX-101.LAB 33476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20190930_pre.xml EX-101.PRE 21965
9 EXTRACTED XBRL INSTANCE DOCUMENT tv530212_8k_htm.xml XML 3545
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 191127591
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences